Nine year follow-up study of morbidity and mortality in retinal vein occlusion

Eye

Volumn 14, Issue 6, 2000, Pages 821-827

  Tsaloumas, M D ^a   Kirwan, J ^a   Vinall, H ^a   O'leary M B ^a   Prior, P ^a   Kritzinger, E E ^a   Dodson, P M ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

Morbidity; Mortality; Retinal vein occlusion

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GEOGRAPHY; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IRIS RUBEOSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; RECURRENCE RISK; RECURRENT DISEASE; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; SMOKING; STROKE; SURVIVAL;

EID: 0034529814     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Retinal vein occlusion and the prevalence of lipoprotein abnormalities
2. Management of retinal vein occlusion
3. Does type II diabetes predispose to retinal vein occlusion?
4. Factors associated with retinal vein occlusion in Hispanics
5. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion
6. Risk factors for retinal vein occlusions: A case controlled study
7. Abnormal blood viscosity and haemostasis in long standing retinal vein occlusion
8. Retinal vein occlusion: C-reactive protein and arterial hypertension
9. Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion
10. Activated protein C resistance in young adults with central retinal vein occlusion
11. Medical conditions underlying recurrence of retinal vein occlusion
12. Branch venous thrombosis: A pathological report
13. Combined branch retinal artery and central retinal vein obstruction
14. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions
15. Arteriovenous crossing patterns in branch retinal vein occlusion
16. Cardiovascular disease in patients with retinal arterial occlusion
17. Systemic factors contributory to retinal vein occlusion
18. Prognosis and prognostic factors of retinal infarction: A prospective cohort study
19. Retinal vein occlusion: Long-term prospects
20. Diabetes mellitus and retinal vein occlusion in patients of Asian, West Indian and white European origin
21. Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorrhage in branch vein occlusion
22. Panretinal photocoagulation in central vein occlusion: A randomised controlled clinical study
23. Neovascular glaucoma following central retinal vein obstruction
24. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics
25. Relation of ocular and systemic factors to survival in diabetes
26. Are there medical conditions specifically underlying the development of rubeosis in central vein occlussion?
27. Viscosity and retinal vein thrombosis
28. Blood viscosity, coagulation, and activated protein C resistance in central vein occlusion: A population controlled study
29. β-Thromboglobulin and platelet factor 4 levels in retinal vein occlusion
30. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment
31. European Stroke Prevention Study 2. Dypiridamole and acetylsalicylic acid in the secondary prevention of stroke
32. Hypertension treatment trials: Update metanalysis
33. Medical cardiovascular treatment trials: Relevant to medical ophthalmology in 1997
34. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials